14Nov 2019

EVALUATION OF SERUM LIPASE LEVEL IN NON DIABETIC CHRONIC KIDNEY DISEASE PATIENTS

  • Professor, Sr.Professor & Head, MD, Assistant Professor Assistant Professor Department of Biochemistry JLN Medical College, Ajmer, Rajasthan, India
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Chronic kidney disease is a progressive loss in renal function over period of many months or years. There is decline in nephron function and number generally quantitated as reduction in glomerular filtration rate. As the GFR declines there is accumulation of metabolic end products excreted by kidney. Serum lipase is mainly marker of pancreatic & hepatobiliary disease but its level is also high in chronic renal disorder. Lipase is filtered by glomerulus and almost completely reabsorbed and metabolised by renal tubules, thus chronic kidney disease patient have elevated serum lipase level. Our study was aimed to find out the status of serum lipase in non diabetic chronic kidney disease subjects and healthy controls. Materials and Methods: The present study is a case control study, conducted on 100 non diabetic chronic kidney disease patients . Cases were selected from Urology and Medical ward of Jawahar Lal Nehru Medical College and Associated Group of Hospitals, Ajmer. Age and sex matched healthy controls (n = 50) were selected from MOPD of Jawahar Lal Nehru Medical College and Associated Group of Hospitals, Ajmer. The present study is approved by Institutional Ethical Committee. Results: The mean activity of serum lipase was significantly higher in non diabetic chronic kidney disease subjects compared to that in the healthy controls (p < 0.0001). 85 out of 100 non diabetic chronic kidney disease patients have higher serum lipase levels than normal (>70 U/L). Conclusion: Serum lipase level was found to be elevated in non diabetic chronic kidney disease patients. The observations of this study has also revealed that 85 out of 100 non diabetic chronic kidney disease patients have higher serum lipase levels than normal (>70 U/L). Serum lipase as a diagnostic tool in recognizing acute pancreatitis leads to false positive results in chronic kidney disease patients. Serum lipase can be used as a biomarker for the early detection of chronic kidney disease in the general population to prevent the morbidity and mortality which are associated with chronic kidney diseases

  1. Di?Angelantonio?E,?Danesh?J,?Eiriksdottir?G.?Renal?function?and risk?of coronary heart?disease in general populations: new prospective study and systematic review. PLOS Med?2007?; 4 : 1497 -1507
  2. Liao, Min-Tser; Sung, Chih-Chien; Hung, K .?"Insulin Resistance in Patients with Chronic Kidney Disease".?Journal of Biomedicine and Biotechnology Volume?2012?(2012), Article ID?691369,12 pages doi:10.1155/2012/691369
  3. Kidney failure, also known as end-stage kidney disease, is a?medical?condition in which the ..... up to: "What is renal failure?".?Johns Hopkins Medicine. Archived from the original on 18 June 2017.?Retrieved 18 December 2017.
  4. Brenner BM and Anderson S. The inter relationships among filtration surface area, blood pressure and chronic renal disease. Journal of Cardiovascular Pharmacology1992;19 (suppl 6):S1?7
  5. Remuzzi G., Ruggenenti P. and Benigni A. (1997) Understanding the nature of renal disease progression. Kidney Int 1997; 51(1): 2-15.
  6. Ots M, Pechter U and Tamm A. Characteristics of progressive renal disease. Clinica Chimica Acta 2000; 297:29?41.
  7. GBD 2015 Mortality and Causes of Death, Collaborators. "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015".(8 October 2016). 388 (10053): 1459?1544
  8. Jacobson H.R. Chronic renal failure: pathophysiology. 1991(Aug17); Lancet :338 (8764) :419-42
  9. Tryggvason K. and Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. 2003;J Intern Med 254(3):216-224.
  10. Tietz NW, Shuey DF. Lipase in serum ? the elusive enzyme: an overview. 1993; Clin Chem 39(5):746?756.
  11. Lott JA, Lu CJ. Lipase isoforms and amylase isoenzymes: assays and application in the diagnosis of acute pancreatitis.1991;Clin Chem 37(3):361?
  12. Royse VL, Jensen DM, Corwin HL (1987). Pancreatic enzymes in chronic renal failure. 1987(Mar);Arch Intern Med.147 (3):537 -539.
  13. Jiang CF , Ng KW, Tan SW, Wu CS, Chen HC, Liang CT, Chen YH. Serum level of amylase and lipase in various stages of chronic renal insufficiency. Zhonghua Yi Xue Za Zhi?(Taipei).2002; 65(2):49 -54.
  14. Vaziri ND, Chang D, Malekpour A, Radaht S. Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. Am J Gastroenterol 1988; 83(4) :410-412
  15. Lott JA, Patel ST, Sawhney AK, Kazmierczak SC, Love JE Jr. (1986) Assays of serum lipase: analytical and clinical considerations. Chem. 1986;? 32(7):1290?1302.
  16. Chen CC, Wang SS, Chen TW, Jap TS, Chen SJ. Serum procarboxypeptidase B, amylase and lipase in chronic renal failure. J Gastroenterol Hepatol .1996; 11:496?499.
  17. Masoero G, Bruno M, Gallo L, Colaferro S, Cosseddu D, Vacha GM.(1996) Increased serum pancreatic enzymes in uremia: relation with treatment modality and pancreatic involvement. .. Pancreas.?1996?(Nov);13(4):350-355.

[Sarla Mahawar, Deepa Thadani, Anupam lata jakhalia, Varsha Chowdhry and Asha Makwana (2019); EVALUATION OF SERUM LIPASE LEVEL IN NON DIABETIC CHRONIC KIDNEY DISEASE PATIENTS Int. J. of Adv. Res. 7 (Nov). 537-541] (ISSN 2320-5407). www.journalijar.com

Dr. Deepa Thadani
RUHS

DOI:

Article DOI: 10.21474/IJAR01/10042      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10042

Download Full Paper

Download PDF No. of Downloads: 11 | No. of Views: 69